Clinical Trial

Sulfasalazine in Patients With Metastatic Colorectal Cancer

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated November 18, 2023 (before its estimated September 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate the potential efficacy and safety of sulfasalazine in patients with metastatic colorectal cancer.
Trial Details
NCT Number NCT06134388
Lead Sponsor Tanta University
Conditions Metastatic Colorectal Cancer
Enrollment 50 participants
Start Date 2023-09-01
Primary Completion 2025-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2023-11-18